SAB BIOTHERAPEUTICS INC
SABS·78397T202·US·Common Stock·Healthcare - Biotechnology-Activist
SABS (SAB BIOTHERAPEUTICS INC) is held by 57 institutional investors as of Q2 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($25M), RA CAPITAL MANAGEMENT, L.P. ($17.2M), BALYASNY ASSET MANAGEMENT L.P. ($14.7M). Net institutional sentiment: Bullish.
57
Holders
(1 Elite)
$124M
Total Value
68% (65)
Consensus
44 buying - 21 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 9, 2026 · Insiders Sep 18, 2026 · Activists Aug 14, 2026 · Congress none
InsiderKAKropotova AlexandraTax 473 shSep 17, 2026
ActivistPAPerceptive Advisors LLC7.3%Aug 14, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 70
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
416 holders · $299.1B
415 holders · $877.5B
400 holders · $151.4B
397 holders · $414.1B
394 holders · $97.5B
393 holders · $111.5B
390 holders · $230.1B
385 holders · $302.9B
385 holders · $51.8B
382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer